Novel MFSD8 mutation causing non-syndromic asymmetric adult-onset macular dystrophy

References

• Daiger S, Sullivan L, Bowne S. RetNet: summaries of genes and loci causing retinal diseases. https://sph.uth.edu/retnet/home.htm.
   Google Scholar
• Roosing S, van den Born LI, Sangermano R, Banfi S, Koenekoop RK, Zonneveld-Vrieling MN, Klaver CC, van Lith-Verhoeven JJ, Cremers FP, den Hollander AI, Hoyng CB. Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy. Ophthalmology. 2015;122(1):170–79. doi:10.1016/j.ophtha.2014.07.040.
   PubMed Web of Science ®Google Scholar
• Siintola E, Topcu M, Aula N, Lohi H, Minassian BA, Paterson AD, Liu, XQ, Wilson, C, Lahtinen, U, Anttonen, AK, et al. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am J Hum Genet. 2007;81(1):136–46. doi:10.1086/518902.
   PubMed Web of Science ®Google Scholar
• Steenhuis P, Herder S, Gelis S, Braulke T, Storch S. Lysosomal targeting of the CLN7 membrane glycoprotein and transport via the plasma membrane require a dileucine motif. Traffic. Jul 1 2010;11(7):987–1000. doi:10.1111/j.1600-0854.2010.01073.x.
   PubMedGoogle Scholar
• Mole S. NCL resource - a gateway for batten disease. 2021. https://www.ucl.ac.uk/ncl/CLN7mutationtable.htm.
   Google Scholar
• Khan KN, El-Asrag ME, Ku CA, Holder GE, McKibbin M, Arno G, Poulter JA, Carss K, Bommireddy T, Bagheri S, et al. Specific alleles of CLN7/MFSD8, a protein that localizes to photoreceptor synaptic terminals, cause a spectrum of nonsyndromic retinal dystrophy. Invest Ophthalmol Vis Sci. 2017;58(7):2906–14. doi:10.1167/iovs.16-20608.
   PubMedGoogle Scholar
• Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Holthaus SMK, McKay TR, Medina DL, Rahim AA, Schulz A, et al. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol. 2019;18(1):107–16. doi:10.1016/S1474-4422(18)30368-5.
   PubMed Web of Science ®Google Scholar
• Radke J, Stenzel W, Goebel HH. Human NCL neuropathology. Biochim Biophys Acta. 2015;1852(10 Pt B):2262–66. doi:10.1016/j.bbadis.2015.05.007.
   PubMedGoogle Scholar
• Xiang Q, Cao Y, Xu H, Yang Z, Tang L, Xiang J, Li J, Deng H, Yuan L. Novel. J Ophthalmol. 2021;2021:6684045. doi:10.1155/2021/6684045.
   PubMedGoogle Scholar
• Zare-Abdollahi D, Bushehri A, Alavi A, Dehghani A, Mousavi-Mirkala M, Effati J, Miratashi SAM, Dehani M, Jamali P, Khorram Khorshid HR. MFSD8 gene mutations; evidence for phenotypic heterogeneity. Ophthalmic Genet. 2019;40(2):141–45. doi:10.1080/13816810.2019.1592200.
   PubMed Web of Science ®Google Scholar
• Birtel J, Gliem M, Mangold E, Müller PL, Holz FG, Neuhaus C, Lenzner S, Zahnleiter D, Betz C, Eisenberger T, et al. Next-Generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa. PLoS One. 2018;13(12):e0207958. doi:10.1371/journal.pone.0207958.
   PubMed Web of Science ®Google Scholar
• Bauwens M, Storch S, Weisschuh N, Ceuterick‐de Groote C, De Rycke R, Guillemyn B, De Jaegere S, Coppieters F, Van Coster R, Leroy BP, et al. Functional characterization of novel MFSD8 pathogenic variants anticipates neurological involvement in juvenile isolated maculopathy. Clin Genet. 2020; 97(3):426–36. doi:10.1111/cge.13673.
   PubMedGoogle Scholar
• Aiello C, Terracciano A, Simonati A, et al. Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis. Hum Mutat. 2009;30(3):E530–40. doi:10.1002/humu.20975.
   PubMedGoogle Scholar
• Gao FJ, Qi YH, Hu FY, Discepoli G, Cannelli N, Claps D, Crow YJ, Bianchi M, Kitzmuller C, Longo D, et al. Mutation spectrum of the bestrophin-1 gene in a large Chinese cohort with bestrophinopathy. Br J Ophthalmol. 2020;104(6):846–51. doi:10.1136/bjophthalmol-2019-314679.
   PubMedGoogle Scholar
• Astuti GD, Bertelsen M, Preising MN, Ajmal M, Lorenz B, Faradz, SM, Qamar R, Collin, RW, Rosenberg T, Cremers, FP. Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark. Eur J Hum Genet. 2016; 24(7):1071–79. doi:10.1038/ejhg.2015.241.
   PubMed Web of Science ®Google Scholar
• Kmoch S, Majewski J, Ramamurthy V, Cao S, Fahiminiya S, Ren H, MacDonald IM, Lopez I, Sun V, Keser V, et al. Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness. Nat Commun. 2015 Jan 9;6:5614. doi:10.1038/ncomms6614.
   PubMed Web of Science ®Google Scholar
• Wivestad Jansson R, Berland S, Bredrup C, Austeng D, Andréasson S, Wittström E. Biallelic mutations in the BEST1 gene: additional families with autosomal recessive bestrophinopathy. Ophthalmic Genet. 2016;37(2):183–93. doi:10.3109/13816810.2015.1020558.
   PubMed Web of Science ®Google Scholar
• MacDonald IM, Lee T, Lawrence J. Bestrophinopathies. In: Adam M, Ardinger H, Pagon R, et al., editors. GeneReviews(®). University of Washington, Seattle Copyright © 1993-2022, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.
   Google Scholar
• Cai X, Conley SM, Naash MI. RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet. 2009;30(2):57–62. doi:10.1080/13816810802626399.
   PubMed Web of Science ®Google Scholar
• Hartzell HC, Qu Z, Yu K, Xiao Q, Chien LT. Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev. 2008;88(2):639–72. doi:10.1152/physrev.00022.2007.
   PubMed Web of Science ®Google Scholar